EGFR and non-small cell lung carcinoma: Leung et al. [28] demonstrated the usefulness of ctDNA as a diagnostic test in patients with early stage NSCLC, analyzing the presence of EGFR, KRAS, and p53 mutations, mostly frequent in adenocarcinoma and epidermoid lung carcinoma.